Evercore ISI analyst Liisa Bayko maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report) on January 31 and set a price target of $515.00. The company’s shares closed last ...
In a report released on January 31, Chris McNally from Evercore ISI maintained a Buy rating on Autoliv (ALV – Research Report), with a price target of $140.00. The company’s shares closed last ...
After hours: February 3 at 6:19:07 p.m. EST ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback